Suppr超能文献

采用高清晰度质谱技术鉴定肝细胞癌的新型生物标志物:超高效液相色谱-四极杆飞行时间质谱和解吸电喷雾电离质谱成像。

Identification of novel biomarkers of hepatocellular carcinoma by high-definition mass spectrometry: Ultrahigh-performance liquid chromatography quadrupole time-of-flight mass spectrometry and desorption electrospray ionization mass spectrometry imaging.

机构信息

Laboratory of Oncology, Pharmacy Practice and Sciences, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan.

Department of Clinical Laboratory Medicine, University of Tokyo, Japan.

出版信息

Rapid Commun Mass Spectrom. 2020 Apr;34 Suppl 1(Suppl 1):e8551. doi: 10.1002/rcm.8551. Epub 2019 Nov 6.

Abstract

RATIONALE

Hepatocellular carcinoma (HCC) is a highly malignant disease for which the development of prospective or prognostic biomarkers is urgently required. Although metabolomics is widely used for biomarker discovery, there are some bottlenecks regarding the comprehensiveness of detected features, reproducibility of methods, and identification of metabolites. In addition, information on localization of metabolites in tumor tissue is needed for functional analysis. Here, we developed a wide-polarity global metabolomics (G-Met) method, identified HCC biomarkers in human liver samples by high-definition mass spectrometry (HDMS), and demonstrated localization in cryosections using desorption electrospray ionization MS imaging (DESI-MSI) analysis.

METHODS

Metabolic profiling of tumor (n = 38) and nontumor (n = 72) regions in human livers of HCC was performed by an ultrahigh-performance liquid chromatography quadrupole time-of-flight MS (UHPLC/QTOFMS) instrument equipped with a mixed-mode column. The HCC biomarker candidates were extracted by multivariate analyses and identified by matching values of the collision cross section and their fragment ions on the mass spectra obtained by HDMS. Cryosections of HCC livers, which included both tumor and nontumor regions, were analyzed by DESI-MSI.

RESULTS

From the multivariate analysis, m/z 904.83 and m/z 874.79 were significantly high and low, respectively, in tumor samples and were identified as triglyceride (TG) 16:0/18:1(9Z)/20:1(11Z) and TG 16:0/18:1(9Z)/18:2(9Z,12Z) using the synthetic compounds. The TGs were clearly localized in the tumor or nontumor areas of the cryosection.

CONCLUSIONS

Novel biomarkers for HCC were identified by a comprehensive and reproducible G-Met method with HDMS using a mixed-mode column. The combination analysis of UHPLC/QTOFMS and DESI-MSI revealed that the different molecular species of TGs were associated with tumor distribution and were useful for characterizing the progression of tumor cells and discovering prospective biomarkers.

摘要

背景

肝细胞癌(HCC)是一种高度恶性的疾病,迫切需要开发前瞻性或预后性生物标志物。尽管代谢组学广泛用于生物标志物的发现,但在检测特征的全面性、方法的可重复性和代谢物的鉴定方面存在一些瓶颈。此外,还需要了解肿瘤组织中代谢物的定位信息,以进行功能分析。在这里,我们开发了一种广极性全局代谢组学(G-Met)方法,通过高清晰度质谱(HDMS)鉴定人肝组织中 HCC 的生物标志物,并通过解吸电喷雾电离 MS 成像(DESI-MSI)分析在冷冻切片中进行定位。

方法

通过配备混合模式柱的超高效液相色谱四极杆飞行时间 MS(UHPLC/QTOFMS)仪器对 HCC 患者肝组织的肿瘤(n=38)和非肿瘤(n=72)区域进行代谢谱分析。通过多元分析提取 HCC 生物标志物候选物,并通过匹配 HDMS 获得的质谱中碰撞截面及其碎片离子的值进行鉴定。对包含肿瘤和非肿瘤区域的 HCC 肝冷冻切片进行 DESI-MSI 分析。

结果

从多元分析中,m/z 904.83 和 m/z 874.79 在肿瘤样本中分别显著升高和降低,被鉴定为甘油三酯(TG)16:0/18:1(9Z)/20:1(11Z)和 TG 16:0/18:1(9Z)/18:2(9Z,12Z),使用合成化合物。TG 在冷冻切片的肿瘤或非肿瘤区域中清晰定位。

结论

通过使用混合模式柱的 HDMS 进行全面和可重复的 G-Met 方法,鉴定了 HCC 的新型生物标志物。UHPLC/QTOFMS 和 DESI-MSI 的联合分析表明,TG 的不同分子物种与肿瘤分布有关,可用于表征肿瘤细胞的进展并发现有前景的生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10cf/7154627/28c9441ad9d0/RCM-34-e8551-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验